Treatment of Q Fever
For acute Q fever, treat adults with doxycycline 100 mg twice daily for 14 days; for chronic Q fever with endocarditis or vascular infection, use combination therapy with doxycycline 100 mg twice daily plus hydroxychloroquine 200 mg three times daily for at least 18 months. 1
Acute Q Fever Treatment
Adults
- Doxycycline 100 mg orally twice daily for 14 days is the first-line treatment 1
- Doxycycline may be taken with food to minimize gastrointestinal upset, but avoid dairy products within 2 hours before or after dosing 1
- Prophylactic treatment after potential exposure is not recommended; treatment is also not indicated for asymptomatic infections or after symptom resolution 1
- Consider treatment in high-risk individuals (those with valvular disease, immunocompromised status, or pregnancy) even after symptoms resolve to prevent progression to chronic disease 1
Pregnant Women
- Trimethoprim/sulfamethoxazole 160 mg/800 mg twice daily throughout pregnancy is the recommended regimen 1
- Doxycycline is contraindicated during pregnancy 1
- This treatment reduces risk of placentitis, obstetric complications (including intrauterine fetal death), and maternal progression to chronic Q fever 1
- Women should avoid pregnancy for at least 1 month after acute Q fever diagnosis and treatment 1
- Infectious disease consultation is recommended given limited data on treatment during pregnancy 1
Children
Age ≥8 years:
- Doxycycline 2.2 mg/kg per dose twice daily for 14 days (maximum 100 mg per dose) 1
Age <8 years with high-risk criteria:
- Doxycycline 2.2 mg/kg per dose twice daily for 14 days (maximum 100 mg per dose) 1
- High-risk criteria include: hospitalization or severe illness, preexisting heart valvulopathy, immunocompromised status, or delayed diagnosis with illness >14 days without resolution 1
Age <8 years with mild or uncomplicated illness:
- Doxycycline 2.2 mg/kg per dose twice daily for 5 days (maximum 100 mg per dose) 1
- If fever persists beyond 5 days: switch to trimethoprim/sulfamethoxazole 4-20 mg/kg twice daily for 14 days (maximum 800 mg per dose) 1
- Short courses (≤5 days) of doxycycline have not been shown to cause significant dental staining, though the risk with 14-day courses remains unknown 1
Chronic Q Fever Treatment
Endocarditis or Vascular Infection
- Doxycycline 100 mg twice daily PLUS hydroxychloroquine 200 mg three times daily for ≥18 months 1
- Target serum doxycycline levels ≥5 μg/mL for optimal efficacy 1
- Target serum hydroxychloroquine levels 1.0 ± 0.2 μg/mL 1
- Hydroxychloroquine should be taken with food or milk 1
- Monitor for retinal toxicity with hydroxychloroquine use 1
- Contraindicated in patients with glucose-6-phosphate dehydrogenase deficiency 1
- Treatment duration may extend to 24 months depending on serologic response 2
- Pediatric and pregnant patients require infectious disease consultation 1
Noncardiac Organ Disease
- Same regimen as endocarditis: doxycycline 100 mg twice daily plus hydroxychloroquine 200 mg three times daily 1
- Duration depends on serologic response 1
- Infectious disease consultation recommended, as limited data exist for osteoarticular infections or chronic hepatitis 1
Postpartum Women with Chronic Q Fever Serology
- Treat only if serologic titers remain elevated >12 months after delivery (IgG phase I titer ≥1:1024) 1
- Regimen: doxycycline 100 mg twice daily plus hydroxychloroquine 200 mg three times daily for 12 months 1
- Women treated during pregnancy for acute Q fever require serologic monitoring at 3,6,12,18, and 24 months after delivery 1
Important Clinical Considerations
Monitoring and Follow-up
- Women with Q fever during pregnancy are at risk for recrudescent infection in subsequent pregnancies and require close monitoring 1
- Patients at high risk for chronic disease progression require long-term serologic surveillance 1
Alternative Therapies
- Quinolones may be used in patients intolerant to hydroxychloroquine for chronic Q fever 1
- Rifampin can be added as an alternative to hydroxychloroquine in chronic disease 3
- Co-trimoxazole is an established alternative for patients unable to tolerate doxycycline 2